| Authors: |
Mathai DS; Ethical Legal Implications of Psychedelics in Society Program, Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.; Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.; Sattva Medicine, Psychiatry, Psychotherapy, and Consulting Practice, Miami, FL, USA., Roberts DE; Center for Psychedelic Medicine, Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA., Nayak SM; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Sepeda ND; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center for Psychedelic Drug Research and Education, College of Social Work, The Ohio State University, Columbus, OH, USA., Lehrner A; Center for Psychedelic Psychotherapy and Trauma Research, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Johnson MW; Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center of Excellence in Psilocybin Research and Treatment, Sheppard Pratt, Towson, MD, USA., Lowe MX; Unlimited Sciences, Colorado Springs, CO, USA., Jackson H; Unlimited Sciences, Colorado Springs, CO, USA., Garcia-Romeu A; Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. |
